{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:24:17Z","timestamp":1787757857908,"version":"build-2784847793"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Catatonia is a diagnostic entity of a neuropsychiatric cluster of symptoms that can occur in a number of different psychiatric, neurologic, and metabolic disorders. Benzodiazepines remain the mainstay of the treatment of catatonia through their possible effect on the gamma-aminobutyric acid (GABA) receptor modulation in the central nervous system (CNS). Rarely, patients have been seen to manifest catatonic symptoms when they face sudden withdrawal from long-term benzodiazepine treatment. Here, we have presented two such cases of different clinical profiles where following benzodiazepine withdrawal, sudden catatonic symptoms emerged that responded quickly on re-administration of benzodiazepines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ipj.ipj_265_21","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T03:23:31Z","timestamp":1653017011000},"page":"165-167","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Benzodiazepine withdrawal catatonia"],"prefix":"10.4103","volume":"31","author":[{"given":"Uttam","family":"Majumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avik K.","family":"Layek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20240829","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.genhosppsych.2012.01.011","article-title":"Clinical predictors of response to treatment in catatonia","volume":"34","author":"Narayanaswamy","year":"2012","journal-title":"Gen Hosp Psychiatry"},{"key":"R2-25-20240829","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/0019-5545.117131","article-title":"Diagnostic and statistical manual of mental disorders 5: A quick glance","volume":"55","author":"Vahia","year":"2013","journal-title":"Indian J Psychiatry"},{"key":"R3-25-20240829","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.psym.2016.01.007","article-title":"How anti-NMDAR encephalitis sheds light on the mechanisms underlying catatonia: The neural excitatory\/inhibitory imbalance model","volume":"57","author":"Parenti","year":"2016","journal-title":"Psychosomatics"},{"key":"R4-25-20240829","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fpsyt.2014.00181","article-title":"A clinical review of the treatment of catatonia","volume":"5","author":"Sienaert","year":"2014","journal-title":"Front Psychiatry"},{"key":"R5-25-20240829","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/jnp.2009.21.4.371","article-title":"Catatonia: Clinical aspects and neurobiological correlates","volume":"21","author":"Daniels","year":"2009","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R6-25-20240829","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/00048678209161268","article-title":"Catatonia: The ultimate response to fear?","volume":"16","author":"Perkins","year":"1982","journal-title":"Aust N Z J Psychiatry"},{"key":"R7-25-20240829","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J"},{"key":"R8-25-20240829","first-page":"2324709620969498","article-title":"Benzodiazepine withdrawal catatonia, delirium, and seizures in a patient with schizoaffective disorder","volume":"8","author":"Mader","year":"2020","journal-title":"J Investig Med High Impact Case Rep"},{"key":"R9-25-20240829","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1360-0443.1994.tb03743.x","article-title":"The benzodiazepine withdrawal syndrome","volume":"89","author":"P\u00e9tursson","year":"1994","journal-title":"Addiction"},{"key":"R10-25-20240829","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archneur.1989.00520420118033","article-title":"Benzodiazepine withdrawal delirium with catatonic features. Occurrence in patients with partial seizure disorders","volume":"46","author":"Hauser","year":"1989","journal-title":"Arch Neurol"},{"key":"R11-25-20240829","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00004714-199608000-00007","article-title":"Catatonia after benzodiazepine withdrawal","volume":"16","author":"Rosebush","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"R12-25-20240829","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1176\/appi.psy.50.3.289","article-title":"Clonazepam withdrawal-induced catatonia","volume":"50","author":"Brown","year":"2009","journal-title":"Psychosomatics"},{"key":"R13-25-20240829","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3109\/00048674.2011.607131","article-title":"Catatonia associated with temazepam withdrawal","volume":"45","author":"Parameswaran","year":"2011","journal-title":"Aust N Z J Psychiatry"},{"key":"R14-25-20240829","doi-asserted-by":"crossref","first-page":"e0249222","DOI":"10.1371\/journal.pone.0249222","article-title":"Magnitude and associated factors of poor medication adherence among diabetic and hypertensive patients visiting public health facilities in Ethiopia during the COVID-19 pandemic","volume":"16","author":"Shimels","year":"2021","journal-title":"PLoS One"},{"key":"R15-25-20240829","doi-asserted-by":"crossref","first-page":"e045325","DOI":"10.1136\/bmjopen-2020-045325","article-title":"Depression, anxiety and stress during the COVID-19 pandemic: Results from a New Zealand cohort study on mental well-being","volume":"11","author":"Gasteiger","year":"2021","journal-title":"BMJ Open"},{"key":"R16-25-20240829","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ajp.2013.05.008","article-title":"Lorazepam withdrawal catatonia: A case report","volume":"6","author":"Sivakumar","year":"2013","journal-title":"Asian J Psychiatr"},{"key":"R17-25-20240829","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0253-7176.207338","article-title":"The phenomenology and treatment response in catatonia: A hospital based descriptive study","volume":"39","author":"Swain","year":"2017","journal-title":"Indian J Psychol Med"},{"key":"R18-25-20240829","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2015.055","article-title":"Management of benzodiazepine misuse and dependence","volume":"38","author":"Brett","year":"2015","journal-title":"Aust Prescr"}],"container-title":["Industrial Psychiatry Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ipj.ipj_265_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:55:31Z","timestamp":1787756131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ipj.ipj_265_21"}},"subtitle":["Two cases from a tertiary care center in Eastern India"],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ipj.ipj_265_21","relation":{},"ISSN":["0972-6748"],"issn-type":[{"value":"0972-6748","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}